Cargando…
Comparison of the Protective Effects of Nebivolol and Metoprolol against LPS-Induced Injury in H9c2 Cardiomyoblasts
Here, we, for the first time, compared the cardioprotective effects of third-generation vasodilating beta-blocker nebivolol (Neb) and conventional beta-blocker metoprolol (Met) on LPS-induced injury in H9c2 cardiomyoblasts. Our findings denoted that Neb and Met pretreatment diminish LPS-mediated cyt...
Autores principales: | Gul, Rukhsana, Okla, Meshail, Mahmood, Amer, Nawaz, Shahid, Fallata, Amina, Bazighifan, Arwa, Alfayez, Musaad, Alfadda, Assim A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670410/ https://www.ncbi.nlm.nih.gov/pubmed/37998760 http://dx.doi.org/10.3390/cimb45110583 |
Ejemplares similares
-
Inhibition of eNOS Partially Blunts the Beneficial Effects of Nebivolol on Angiotensin II-Induced Signaling in H9c2 Cardiomyoblasts
por: Gul, Rukhsana, et al.
Publicado: (2022) -
Protective Effects of Nanoceria against Mitochondrial Dysfunction and Angiotensin II-Induced Hypertrophy in H9c2 Cardiomyoblasts
por: Gul, Rukhsana, et al.
Publicado: (2023) -
Regulation of cardiac miR-208a, an inducer of obesity, by Rapamycin and Nebivolol
por: Gul, Rukhsana, et al.
Publicado: (2015) -
A Proteomics-Based Approach Reveals Differential Regulation of Urine Proteins between Metabolically Healthy and Unhealthy Obese Patients
por: Benabdelkamel, Hicham, et al.
Publicado: (2019) -
Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension
por: Yazici, Huseyin Ugur, et al.
Publicado: (2013)